Diet-wide association study of 92 foods and nutrients and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 Dec 2022
Historique:
revised: 01 06 2022
received: 28 10 2021
accepted: 02 06 2022
pubmed: 14 7 2022
medline: 18 10 2022
entrez: 13 7 2022
Statut: ppublish

Résumé

It is unclear whether diet, and in particular certain foods or nutrients, are associated with lung cancer risk. We assessed associations of 92 dietary factors with lung cancer risk in 327 790 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cox regression yielded adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) per SD higher intake/day of each food/nutrient. Correction for multiple comparisons was performed using the false discovery rate and identified associations were evaluated in the Netherlands Cohort Study (NLCS). In EPIC, 2420 incident lung cancer cases were identified during a median of 15 years of follow-up. Higher intakes of fibre (HR per 1 SD higher intake/day = 0.91, 95% CI 0.87-0.96), fruit (HR = 0.91, 95% CI 0.86-0.96) and vitamin C (HR = 0.91, 95% CI 0.86-0.96) were associated with a lower risk of lung cancer, whereas offal (HR = 1.08, 95% CI 1.03-1.14), retinol (HR = 1.06, 95% CI 1.03-1.10) and beer/cider (HR = 1.04, 95% CI 1.02-1.07) intakes were positively associated with lung cancer risk. Associations did not differ by sex and there was less evidence for associations among never smokers. None of the six associations with overall lung cancer risk identified in EPIC were replicated in the NLCS (2861 cases), however in analyses of histological subtypes, inverse associations of fruit and vitamin C with squamous cell carcinoma were replicated in the NLCS. Overall, there is little evidence that intakes of specific foods and nutrients play a major role in primary lung cancer risk, but fruit and vitamin C intakes seem to be inversely associated with squamous cell lung cancer.

Identifiants

pubmed: 35830197
doi: 10.1002/ijc.34211
pmc: PMC9804326
doi:

Substances chimiques

Vitamin A 11103-57-4
Ascorbic Acid PQ6CK8PD0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1935-1946

Subventions

Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24390
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A29017
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Cancer Epidemiol. 2019 Feb;58:25-32
pubmed: 30445228
Lung Cancer. 2001 Feb-Mar;31(2-3):139-48
pubmed: 11165392
Int J Cancer. 2022 Dec 01;151(11):1935-1946
pubmed: 35830197
Clin Gastroenterol Hepatol. 2022 Apr;20(4):864-873.e13
pubmed: 33901663
Lung Cancer. 2015 May;88(2):124-30
pubmed: 25747805
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2436-47
pubmed: 18006934
Eur J Clin Nutr. 1995 Jun;49(6):420-9
pubmed: 7656885
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur J Nutr. 2020 Oct;59(7):2929-2937
pubmed: 31705265
JAMA. 2003 Jul 23;290(4):476-85
pubmed: 12876090
Am J Epidemiol. 1986 Jul;124(1):17-27
pubmed: 3521261
Breast Cancer Res. 2020 Jan 13;22(1):5
pubmed: 31931881
Nutr J. 2002 Nov 19;1:3
pubmed: 12537595
Lung Cancer. 2001 Oct;34(1):37-46
pubmed: 11557111
Sci Rep. 2016 May 27;6:26760
pubmed: 27230571
Eur Respir J. 2016 Sep;48(3):889-902
pubmed: 27174888
Nutr Cancer. 2018 Jan;70(1):1-13
pubmed: 29016198
JAMA. 2010 Jun 16;303(23):2377-85
pubmed: 20551408
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
J Clin Epidemiol. 1990;43(3):285-95
pubmed: 2313318
Am J Clin Nutr. 2016 Jan;103(1):161-7
pubmed: 26607939
Ann Oncol. 2011 Dec;22(12):2631-2639
pubmed: 21427064
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Circulation. 2012 Nov 20;126(21):2456-64
pubmed: 23093587
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):466-71
pubmed: 25662427
N Engl J Med. 1996 May 2;334(18):1150-5
pubmed: 8602180
Ann Oncol. 2016 Jan;27(1):81-96
pubmed: 26371287
Int J Clin Exp Med. 2014 Jun 15;7(6):1542-53
pubmed: 25035778
Eur J Clin Nutr. 1994 Apr;48(4):253-65
pubmed: 8039485
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Cancer Causes Control. 1998 Dec;9(6):621-30
pubmed: 10189048
Am J Epidemiol. 2009 Apr 1;169(7):815-28
pubmed: 19208726
Ann Oncol. 2013 Oct;24(10):2606-2611
pubmed: 23956193

Auteurs

Alicia K Heath (AK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

David C Muller (DC)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Piet A van den Brandt (PA)

Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands.

Elena Critselis (E)

Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.
Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.

Marc Gunter (M)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Paolo Vineis (P)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Bergholz-Rehbrücke, Germany.

Pietro Ferrari (P)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Melissa A Merritt (MA)

Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.

Agnetha L Rostgaard-Hansen (AL)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Verena Katzke (V)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Bernard Srour (B)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Giovanna Masala (G)

Institute of Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy.

Fabrizio Pasanisi (F)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Bas Bueno-de-Mesquita (B)

Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

George S Downward (GS)

Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

Guri Skeie (G)

Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.

Torkjel M Sandanger (TM)

Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.

Marta Crous-Bou (M)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Miguel Rodríguez-Barranco (M)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Pilar Amiano (P)

Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Spain.
Biodonostia Health Research Institute, Epidemiology and Public Health Area, San Sebastián, Spain.
CIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

José María Huerta (JM)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Eva Ardanaz (E)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Isabel Drake (I)

Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

Mikael Johansson (M)

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.

Ingegerd Johansson (I)

Department of Odontology, Section of Cardiology, Umeå University, Umeå, Sweden.

Tim Key (T)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Nikos Papadimitriou (N)

Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Ioanna Tzoulaki (I)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Konstantinos K Tsilidis (KK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH